Hualan Biological Engineering Inc. (SHE: 002007)

Hualan Biological Engineering Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	843.16	993.77	1,099	692.54	1,038	1,064
Trading Asset Securities	1,778	2,115	2,369	2,659	2,986	2,307
Cash & Short-Term Investments	2,622	3,109	3,468	3,352	4,024	3,371
Cash Growth	-18.18%	-10.36%	3.47%	-16.72%	19.38%	36.99%
Accounts Receivable	2,514	2,590	2,410	2,097	2,263	1,121
Other Receivables	16.57	6.95	4.84	7.05	10.45	13.71
Receivables	2,531	3,297	2,759	2,104	2,274	1,135
Inventory	1,906	1,674	1,447	1,359	1,175	1,160
Other Current Assets	2,208	1,247	403.56	36.67	39.31	19.85
Total Current Assets	9,266	9,327	8,077	6,851	7,512	5,685
Property, Plant & Equipment	2,842	2,727	2,290	2,338	1,769	1,337
Long-Term Investments	6.03	3,273	3,673	1,716	110.36	105.13
Goodwill	-	1.1	1.1	1.1	1.1	1.1
Other Intangible Assets	315.93	319.72	310	204.53	195.24	201.51
Long-Term Deferred Tax Assets	207.86	241.72	232.49	201.25	186.08	104.82
Long-Term Deferred Charges	57.63	59.6	42.49	55.42	47.13	36.68
Other Long-Term Assets	3,406	157.3	116.8	170.16	218.04	111.59
Total Assets	16,102	16,106	14,743	11,537	10,039	7,583
Accounts Payable	204.66	197.26	175.49	241.03	162.52	64.6
Accrued Expenses	0.51	1,169	1,071	947.5	971.14	459.73
Short-Term Debt	600	700.35	800.38	800.7	400	-
Current Portion of Long-Term Debt	150.76	300	-	10.18	-	-
Current Portion of Leases	-	0.36	0.44	-	-	-
Current Income Taxes Payable	72.19	63.36	9.7	48.71	180.02	59.09
Current Unearned Revenue	9.79	8.57	14.78	8.28	7.16	14.52
Other Current Liabilities	1,253	142.3	76.53	158.53	195.74	96.54
Total Current Liabilities	2,291	2,581	2,148	2,215	1,917	694.48
Long-Term Debt	-	-	300	190	-	-
Long-Term Leases	8.67	9.15	9.3	-	-	-
Long-Term Unearned Revenue	46.46	51.18	54.37	57.91	17.35	-
Long-Term Deferred Tax Liabilities	44.74	42.82	20.87	10.37	4.29	4.78
Total Liabilities	2,391	2,685	2,533	2,473	1,938	699.26
Common Stock	1,829	1,829	1,824	1,824	1,824	1,403
Additional Paid-In Capital	1,447	1,486	1,415	105.62	101.96	495.87
Retained Earnings	8,468	8,093	7,159	6,448	5,696	4,644
Treasury Stock	-46.75	-48.07	-	-40.59	-93.75	-
Total Common Equity	11,697	11,359	10,398	8,337	7,529	6,543
Minority Interest	2,014	2,062	1,812	727.09	571.87	340.81
Shareholders' Equity	13,711	13,421	12,210	9,064	8,100	6,884
Total Liabilities & Equity	16,102	16,106	14,743	11,537	10,039	7,583
Total Debt	759.43	1,010	1,110	1,001	400	-
Net Cash (Debt)	1,862	2,099	2,358	2,351	3,624	3,371
Net Cash Growth	-18.85%	-10.99%	0.30%	-35.14%	7.52%	36.99%
Net Cash Per Share	1.02	1.15	1.29	1.28	1.99	1.85
Filing Date Shares Outstanding	1,829	1,829	1,824	1,824	1,824	1,824
Total Common Shares Outstanding	1,829	1,829	1,824	1,824	1,824	1,824
Working Capital	6,976	6,745	5,929	4,636	5,595	4,990
Book Value Per Share	6.40	6.21	5.70	4.57	4.13	3.59
Tangible Book Value	11,381	11,039	10,087	8,131	7,332	6,341
Tangible Book Value Per Share	6.22	6.04	5.53	4.46	4.02	3.48
Buildings	-	1,302	1,206	1,256	1,032	1,021
Machinery	-	2,504	2,383	2,433	1,688	1,375
Construction In Progress	-	661.51	216.39	132.96	379.44	109.81

Source: S&P Capital IQ. Standard template. Financial Sources.